Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i
Washington [US], October 25 (ANI): Apple and its suppliers are currently developing components for next-generation sensors in the Apple Watch Series 8 that will allow users to measure their blood glucose levels.
Washington [US], September 8 (ANI): A study led by researchers at the University of Chicago and Indiana University has determined that a protein called elF5A is necessary for driving inflammation in macrophage cells in obesity. Blocking DHPS, the enzyme that modifies and activates elF5A, led
Washington [US], August 1 (ANI): Eating a millet-based diet can reduce the risk of developing type-2 diabetes and help manage blood glucose levels in people with diabetes, suggests a new study.
Washington [US], July 30 (ANI): A new study has shown that eating a millet-based diet can reduce the risk of developing type 2 diabetes and help manage blood glucose levels in people with diabetes.
Hyderabad (Telangana) [India], July 9 (ANI): MSN Laboratories Pvt. Ltd. (MSN) on Friday announced that it has entered into a licence agreement with the Defence Research and Development Organisation (DRDO) for the manufacturing, distribution and marketing of COVID-19 2- Deoxy-D-Glucose (2-DG)
Hyderabad (Telangana) [India], June 28 (ANI): Dr. Reddy's Laboratories Limited on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG), an anti-COVID-19 drug.
Washington [US], June 28 (ANI): New research from the University of California, Irvine reveals how the circadian regulation of glucose production in the liver is lost during lung cancer progression, and how the resulting increase in glucose production may fuel cancer cell growth.
Washington [US], June 14 (ANI): Tech giant Apple is working on new Apple Watch models which could feature an improved screen and updated ultra-wideband support. But more substantial improvements like temperature and blood glucose monitoring will appear in later models.
New Delhi [India], June 9 (ANI): The Defence Research and Development Organisation (DRDO), which developed 2 -Deoxy-D-Glucose (2-DG), a drug used for the treatment of COVID-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industr
Michigan [US], May 22 (ANI): Nearly half a billion people on the planet have diabetes, but most of them aren't getting the kind of care that could make their lives healthier, longer and more productive, according to a new global study of data from people with the condition.
New Delhi [India], May 17 (ANI): Defence Minister Rajnath Singh on Monday lauded the Defence Research and Development Organisation (DRDO) for developing 2-deoxy-D-glucose (2-DG) drug for the treatment of COVID-19.